A targeted treatment with anti-CD19 CAR T-cells results in different responses
Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
FLT3 inhibitors - their role in AML
What has changed in AML treatment in the last 30 years?
CTL019 in pediatric and young adult relapsed/refractory acute lymphoblastic leukemia (ALL) patients